Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson tECVAYLI (teclistamab) — Worldwide currency (FX) impact YoY (%) (%)
Form 8-K EX-99.2 Segment Sales Schedule
Latest, Q3 2026
-0.7%
Period ended Sep 30, 2026
Change on a year earlier
-2.1 pts
1.4% in Q3 2025
History
11 quarters
Since Q1 2024
Sources
11
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | TECVAYLI (teclistamab) — Worldwide currency (FX) impact YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | -0.7% | -2.1 pts | Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗ |
| Q2 2026 | Jun 28, 2026 | 0.4% | -0.3 pts | Form 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗ |
| Q1 2026 | Mar 29, 2026 | 3.4% | +5.1 pts | Form 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗ |
| Q4 2025 | Dec 28, 2025 | 1.9% | +4.1 pts | Form 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗ |
| Q3 2025 | Sep 28, 2025 | 1.4% | +2.2 pts | Form 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗ |
| Q2 2025 | Jun 29, 2025 | 0.7% | +1.3 pts | Form 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗ |
| Q1 2025 | Mar 30, 2025 | -1.7% | -127.7 pts | Form 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗ |
| Q4 2024 | Dec 29, 2024 | -2.2% | – | Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗ |
| Q3 2024 | Sep 29, 2024 | -0.8% | – | Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗ |
| Q2 2024 | Jun 30, 2024 | -0.6% | – | Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 126.0% | – | Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson TECVAYLI (teclistamab) — Worldwide currency (FX) impact YoY (%) (%), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug_tecvayli_fx_yoy
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.